ATXN3 and Machado-Joseph disease: As silencing of mutant ataxin-3 after disease onset has been shown to rescue, to some extent, the neuropathology in a SCA3 mouse model, it can be postulated that cells are able to clear the toxic products when expression of the mutant transgene is stopped [71, 161].